KN046 in Subjects With Advanced Squamous Non-small Cell Lung Cancer

Summary

This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of KN046 plus paclitaxel and carboplatin versus placebo plus paclitaxel and carboplatin in subjects with advanced squamous NSCLC who have not previously received systemic treatment.

Timeline

Start

2020-09-14

Primary completion

2022-08-30

Completion

2023-08-30

Outcome

Met primary endpoint

release “KN046联合含铂化疗治疗晚期不可切除或转移性鳞状非小细胞肺癌Ⅲ期临床研究完成第一次期中分析，达到预设PFS终点” alphamabonc.com ↗

Drugs

Indications